Posted Jun. 28, 2012 at 7:41 a.m.

Premium Lock Cempra strikes drug licensing deal with Scripps Institute

Published: 2012-06-28 07:41:26
Updated: 2012-06-28 07:41:26

Print this blog post
Cempra Cempra

According to Cempra's filing, the drug developer is paying Scripps a one-time license fee of $350,000. The company must also pay Scripps $50,000 annually for the first three years of the agreement and $85,000 from the fourth year onward. If any commercialized products emerge from the agreement, Scripps stands to gain royalties on net sales....

Read More
Read More

WRAL Tech Wire any time: Twitter, Facebook

Copyright 2014 WRAL Tech Wire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL Tech Wire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Frank Vinluan
Life science
Dr. Mike Walden
Tech economy
Vivek Wadhwa
Commentary
Scroll